RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Apple Turns 50: From Garage Startup to AI Crossroads 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Britain Courts Anthropic Amid US Defense Department Dispute 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 
SAN FRANCISCO, Oct. 05, 2016 -- Hagens Berman Sobol Shapiro LLP alerts investors in LifeVantage Corporation (NASDAQ:LFVN) that a securities fraud class action has been filed and the time to apply to be a lead plaintiff is November 14, 2016.
If you purchased or otherwise acquired securities of LFVN between November 4, 2015 and September 13, 2016 and suffered significant losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/LFVN
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
LifeVantage announced on September 13, 2016 that it would not timely file its Annual Report on Form 10-K with the Securities and Exchange Commission. The Company explained that “[f]ollowing an internal review by Company personnel of its policies and procedures, the Company is in the process of reviewing its sales into certain international markets and the revenue and income tax accruals associated with such sales.”
In response to this news, LifeVantage’s stock price dropped approximately 12.7% to close at $9.08 per share on September 14, 2016.
A lawsuit against the Company, filed September 15, 2016, claims that LifeVantage lacked effective internal controls and improperly recognized revenue from its international business.
As of October 4, 2016, the Company has yet to file its Form 10-K with the SEC.
“The accounting rules are fairly clear on when it is proper to recognize revenues and record expenses,” said Hagens Berman partner Reed Kathrein. “Those are not judgment calls and LFVN investors are rightly concerned about the possible outcome of the internal review.” Hagens Berman continues its investigation of LifeVantage.
Whistleblowers: Persons with non-public information regarding LFVN should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email. [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
